List of Excipients in API avobenzone, ecamsule and octocrylene
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing avobenzone, ecamsule and octocrylene
Detailed excipient profiles for avobenzone, ecamsule and octocrylene
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
avobenzone, ecamsule and octocrylene drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
avobenzone, ecamsule and octocrylene drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CYCLOMETHICONE
avobenzone, ecamsule and octocrylene drug variants containing CYCLOMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing CYCLOMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
avobenzone, ecamsule and octocrylene drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
avobenzone, ecamsule and octocrylene drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
avobenzone, ecamsule and octocrylene drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
avobenzone, ecamsule and octocrylene drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
avobenzone, ecamsule and octocrylene drug variants containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
avobenzone, ecamsule and octocrylene drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-32 HYDROGENATED PALM GLYCERIDES
avobenzone, ecamsule and octocrylene drug variants containing PEG-32 HYDROGENATED PALM GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing PEG-32 HYDROGENATED PALM GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOXYETHANOL
avobenzone, ecamsule and octocrylene drug variants containing PHENOXYETHANOL
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing PHENOXYETHANOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
avobenzone, ecamsule and octocrylene drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
avobenzone, ecamsule and octocrylene drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
avobenzone, ecamsule and octocrylene drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
avobenzone, ecamsule and octocrylene drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TROLAMINE
avobenzone, ecamsule and octocrylene drug variants containing TROLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing TROLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
avobenzone, ecamsule and octocrylene drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| L'Oreal USA Products Inc | avobenzone, ecamsule and octocrylene | 49967-017 |
| >Company | >Ingredient | >NDC |
avobenzone, ecamsule and octocrylene drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
